(Total Views: 1005)
Posted On: 01/27/2020 11:05:42 AM
Post# of 79

$EYPT News Article - EyePoint Pharmaceuticals and Ocumension Therapeutics Sign Exclusive License Agreement to Develop and Commercialize DEXYCU for Post-operative Inflammation in Mainland China, Hong Kong, Macau and Taiwan https://marketwirenews.com/news-releases/eyep...90291.html


My Twitter: WhyteStocks